This inventor holds 2 USPTO granted patents and 1 EPO patent. Top assignee: University of Colorado. Active years: 2019-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2019-2022
Title: Lindsey Gano: Innovator in Vascular Health
Introduction
Lindsey Gano is a notable inventor based in Denver, CO (US), recognized for his contributions to the field of vascular health. He holds 2 patents that focus on innovative methods for treating vascular endothelial dysfunction. His work is significant in advancing medical treatments that can improve patient outcomes.
Latest Patents
Gano's latest patents include methods for the treatment of vascular endothelial dysfunction using nicotinamide mononucleotide. The first patent outlines a method that involves administering a composition comprising nicotinamide mononucleotide and a pharmaceutical excipient to a subject. The second patent also focuses on the compositions and methods for assessing and treating vascular endothelial dysfunction, emphasizing the administration of nicotinamide mononucleotide in response to specific indicators or chronically to subjects.
Career Highlights
Lindsey Gano is affiliated with the University of Colorado, where he continues to engage in research and development in the field of vascular health. His innovative approaches have the potential to transform treatment protocols and enhance the quality of life for individuals suffering from vascular issues.
Collaborations
Gano collaborates with esteemed colleagues such as Douglas R Seals and Natalie Poliektor, who contribute to his research endeavors and help advance the understanding of vascular health.
Conclusion
Lindsey Gano's work in developing methods for treating vascular endothelial dysfunction showcases his commitment to innovation in healthcare. His patents reflect a significant step forward in medical treatments, and his collaborations further enhance the impact of his research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
